Effects of combined treatment with sansanmycin and macrolides on Pseudomonas aeruginosa and formation of biofilm.
- Author:
Yue LI
1
;
Yun-Ying XIE
;
Ru-Xian CHEN
;
Hong-Zhang XU
;
Guo-Ji ZHANG
;
Jin-Zhe LI
;
Xiao-Mian LI
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Anti-Bacterial Agents; administration & dosage; pharmacology; Bacterial Adhesion; drug effects; Biofilms; growth & development; Cercopithecus aethiops; Drug Therapy, Combination; Macrolides; administration & dosage; pharmacology; Microbial Sensitivity Tests; Oligopeptides; administration & dosage; pharmacology; Pseudomonas aeruginosa; drug effects; physiology; ultrastructure; Uridine; administration & dosage; analogs & derivatives; pharmacology; Vero Cells
- From: Biomedical and Environmental Sciences 2009;22(2):170-177
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo observe the effects of combined treatment with sansanmycin and macrolides on Pseudomonas aeruginosa and formation of biofilm.
METHODSMicro-dilution method was used to determine the minimal inhibitory concentrations (MICs) of sansanmycin, gentamycin, carbenicillin, polymyxin B, roxithromycin, piperacillin, and tazobactam. PA1 and PA27853 biofilms were observed under optical microscope after staining and under SEM after treatment with sansanmycin at different dosages and combined treatment with sansanmycin and roxithromycin. Viable bacteria in PA1 and PA27853 biofilms were counted after treatment with sansanmycin at different dosages or combined treatment with sansanmycin and roxithromycin.
RESULTSThe MIC of sansanmycin was lower than that of gentamycin and polymyxin B, but was higher than that of carbenicillin. Roxithromycin enhanced the penetration of sansanmycin to PA1 and PA27853 strains through biofilms. PA1 and PA27853 biofilms were gradually cleared with the increased dosages of sansanmycin or with the combined sansanmycin and roxithromycin.
CONCLUSIONSub-MIC levels of roxithromycin and sansanmycin substantially inhibit the generation of biofilms and proliferation of bacteria. Therefore, combined antibiotics can be used in treatment of intractable bacterial infection.
